about
Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discoveryClinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic diseasePersistent platelet activation in patients with type 2 diabetes treated with low doses of aspirinCD40 ligand as a potential biomarker for atherosclerotic instabilityClinical significance of elevated serum soluble CD40 ligand levels as a diagnostic and prognostic tumor marker for pancreatic ductal adenocarcinoma.Novel biomarkers for cardiovascular risk prediction.Acute suppression of circulating sCD40L during hyperglycemia and euglycemic-hyperinsulinemia in healthy young males.CD40L and Its Receptors in Atherothrombosis-An UpdatePlatelet activity and cardiovascular risk in apparently healthy individuals: a review of the data.Reproducibility over time and effect of low-dose aspirin on soluble P-selectin and soluble CD40 ligand.The levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese people.The Levels of Inflammatory Markers in the Treatment of Stroke study (LIMITS): inflammatory biomarkers as risk predictors after lacunar stroke.Vascular effects of ultrafine particles in persons with type 2 diabetesMultifunctional CD40L: pro- and anti-neoplastic activity.Racial differences in the burden of coronary artery calcium and carotid intima media thickness between Blacks and Whites.Inflammatory bio-markers and cardiovascular risk prediction.Soluble CD40 ligand and prolactin levels in migraine patients during interictal periodProtein kinase C beta mediates CD40 ligand-induced adhesion of monocytes to endothelial cells.Effect of clopidogrel on the expression of inflammatory markers in rabbit ischemic coronary artery.The effect of clopidogrel on platelet activity in patients with and without type-2 diabetes mellitus: a comparative study.PPARγ ligands decrease hydrostatic pressure-induced platelet aggregation and proinflammatory activityPremature labor: a state of platelet activation?Effect of oral and vaginal hormonal contraceptives on inflammatory blood biomarkersActivated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients.Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiography.Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac CatheterizationCandidate-based proteomics in the search for biomarkers of cardiovascular disease.Biomarkers of chronic inflammatory state in uremia and cardiovascular disease.Cardiovascular risk factors and menstrual cycle phase in pre-menopausal women.Novel biomarkers for risk stratification and identification of life-threatening cardiovascular disease: troponin and beyondClopidogrel Improves Skin Microcirculatory Endothelial Function in Persons With Heightened Platelet Aggregation.Inflammatory markers: linking unstable plaques to coronary event, an interventional perspective.Platelet function testing in cardiovascular diseases.Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role.Anti-inflammatory effects of statins: clinical evidence and basic mechanisms.Soluble CD40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling.Clinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension.Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions.Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update.Present and future biochemical markers for detection of acute coronary syndrome.
P2860
Q21285000-2C724D7A-9253-4531-A65B-788D084F6D0DQ28218124-B7A43CA8-6F4D-40EA-87E1-5AB9879D8AA5Q28219419-7BE10E9B-506A-48D1-808C-10FBF415306FQ28288474-BEF8371D-64CC-47BC-947E-CE14C4935154Q33614030-54FAAB2E-68A2-488C-8158-C3D866372CD1Q33615459-9D02D885-A48B-4B98-9B0F-0F54ABB1D6EEQ33768652-FC01912D-700C-4DCC-9593-8AD22C08412BQ33814059-EE07AC57-C91A-4F2B-BCD3-2835613033AAQ33896059-43E0D3E6-3780-44D1-9B4A-78C1F7C864A4Q33912722-FAD40845-E2E5-491F-AD00-18CBBAF670B6Q34020389-349701F2-DC40-4EEF-8EE3-6945B8A8AF6BQ34054032-D6DA12E2-BBBB-43BD-9101-8CECF3E51758Q34407458-E408CFCA-4E88-4791-85C6-EB0CD841DCE0Q34422566-138F399B-F6F4-4D45-ABE0-45E94223807DQ34716166-27A0837E-C61C-4356-9B5B-04B29DE02AB9Q34941391-68ADEC2B-26B8-4973-B3AA-29C156E3F3DDQ34981885-401FBF9E-F758-4945-8355-C9B3B725810FQ34988499-63FA2896-F8F7-460B-B515-9D24237308B5Q35049195-0497BEF2-F6F5-4FE8-8B24-5FFAA5D78475Q35073622-B073974A-0BBD-4FD3-8A26-93F0F5CAC2B7Q35107836-85D81C18-9720-47C9-BE9D-2613C8BA32FEQ35185510-32793E81-02FD-4661-9BB7-280B50B75F66Q35230060-ED1ACE2D-73C1-4FEA-92AE-0DBEFA107A67Q35596004-920EB36A-7B1F-4DDA-9488-98093C703C88Q35633740-E95C716A-FDCA-47D6-963B-732150BC2762Q35735264-A0199ECD-3229-48F7-A7CF-421DEF6609CFQ35990040-CB8C69D2-0C3C-48AB-A2C7-3BBA887F1F88Q36026534-F5F7CCCF-6BF7-44DC-9DAD-5F6DF6C340D3Q36106647-942EFD93-B74E-429D-AAD5-302BA2D703D6Q36120710-98020990-FA5F-4D8F-9D1D-0FC8E84E1790Q36178772-840B7AC8-4A85-497A-BE78-88BCD18AE648Q36251197-DF60665B-33F0-44A8-8AA8-3F8813DBA990Q36270009-9950E8AA-2727-4B77-9A60-9B64BBCD691EQ36318136-E30CFD49-5E28-4486-BB01-59A165C72268Q36337932-8B6AAB8A-D70F-4512-BCCB-1C9A309B5C3EQ36350146-898D9613-683D-4B62-A4AF-B6D52F8F741AQ36359500-040A8F08-C378-4F11-9934-E0AD34681541Q36452637-F6B94E44-4872-4169-81FC-31CDE947D840Q36598022-3A26C154-2614-49DD-A258-55BF034B1713Q36624223-464AC287-4E4A-4AED-A025-4F81382C2369
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Soluble CD40L and cardiovascular risk in women.
@en
type
label
Soluble CD40L and cardiovascular risk in women.
@en
prefLabel
Soluble CD40L and cardiovascular risk in women.
@en
P2093
P356
P1433
P1476
Soluble CD40L and cardiovascular risk in women.
@en
P2093
P304
P356
10.1161/HC4401.099447
P407
P577
2001-11-01T00:00:00Z